Matches in SemOpenAlex for { <https://semopenalex.org/work/W4321438881> ?p ?o ?g. }
- W4321438881 endingPage "122763" @default.
- W4321438881 startingPage "122763" @default.
- W4321438881 abstract "In this study, we prepared a β-cyclodextrin polymer (β-CDP) co-loaded quercetin (QCT) and doxorubicin (DOX) nanocarrier (β-CDP/QD NCs) by freeze-dried method to combat P-glycoprotein (P-gp) mediated multidrug resistance (MDR) in KB-ChR 8–5 cancer cells. Various microscopic and spectroscopic techniques were employed to characterize the prepared nanocarrier. The molecular docking studies confirm the effective binding interactions of QCT and DOX with the synthesized β-CD polymer. The in vitro drug release study illustrates the sustainable release of DOX and QCT from the β-CDP nanocarrier. Further, we noticed that the QCT released from the β-CDP nanocarrier improved the intracellular availability of DOX via modulating P-gp drug efflux function in KB-ChR 8–5 cells and MCF-7/DOX cancer cells. Cell uptake results confirmed the successful internalization of DOX in KB-ChR 8–5 cells compared with free DOX. Cell-based assays such as nuclear condensation, alteration in the mitochondrial membrane potential (MMP), and apoptosis morphological changes confirmed the enhanced anticancer effect of β-CDP/QD NCs in the resistant cancer cells. Hence, QCT and DOX co-loaded β-CDP may be considered effective in achieving maximum cell death in the P-gp overexpressing MDR cancer cells." @default.
- W4321438881 created "2023-02-22" @default.
- W4321438881 creator A5024838157 @default.
- W4321438881 creator A5045709305 @default.
- W4321438881 creator A5045974103 @default.
- W4321438881 creator A5047658039 @default.
- W4321438881 creator A5048127513 @default.
- W4321438881 creator A5061230626 @default.
- W4321438881 creator A5080382262 @default.
- W4321438881 date "2023-03-01" @default.
- W4321438881 modified "2023-09-23" @default.
- W4321438881 title "Enhanced delivery of quercetin and doxorubicin using β-cyclodextrin polymer to overcome P-glycoprotein mediated multidrug resistance" @default.
- W4321438881 cites W1574328107 @default.
- W4321438881 cites W1819045417 @default.
- W4321438881 cites W1824555890 @default.
- W4321438881 cites W1972125312 @default.
- W4321438881 cites W2007807680 @default.
- W4321438881 cites W2019274418 @default.
- W4321438881 cites W2027432937 @default.
- W4321438881 cites W2029667189 @default.
- W4321438881 cites W2089663038 @default.
- W4321438881 cites W2132629607 @default.
- W4321438881 cites W2134967712 @default.
- W4321438881 cites W2139099210 @default.
- W4321438881 cites W2148820466 @default.
- W4321438881 cites W2152368724 @default.
- W4321438881 cites W2204864147 @default.
- W4321438881 cites W2328026762 @default.
- W4321438881 cites W2345918943 @default.
- W4321438881 cites W2412497043 @default.
- W4321438881 cites W2414781026 @default.
- W4321438881 cites W2416418624 @default.
- W4321438881 cites W2478099987 @default.
- W4321438881 cites W2533725785 @default.
- W4321438881 cites W2567338548 @default.
- W4321438881 cites W2593420362 @default.
- W4321438881 cites W2612369911 @default.
- W4321438881 cites W2802924412 @default.
- W4321438881 cites W2887799451 @default.
- W4321438881 cites W2890648216 @default.
- W4321438881 cites W2900474459 @default.
- W4321438881 cites W2938027022 @default.
- W4321438881 cites W2944725533 @default.
- W4321438881 cites W2995471120 @default.
- W4321438881 cites W3000448813 @default.
- W4321438881 cites W3006817825 @default.
- W4321438881 cites W3011127286 @default.
- W4321438881 cites W3011866883 @default.
- W4321438881 cites W3011893711 @default.
- W4321438881 cites W3038743904 @default.
- W4321438881 cites W3041334071 @default.
- W4321438881 cites W3080949917 @default.
- W4321438881 cites W3109452848 @default.
- W4321438881 cites W3111308891 @default.
- W4321438881 cites W3130212252 @default.
- W4321438881 cites W3133044790 @default.
- W4321438881 cites W3162695143 @default.
- W4321438881 cites W3174817415 @default.
- W4321438881 cites W3204390294 @default.
- W4321438881 cites W3211341570 @default.
- W4321438881 cites W4200251931 @default.
- W4321438881 cites W4210447343 @default.
- W4321438881 cites W4226450954 @default.
- W4321438881 doi "https://doi.org/10.1016/j.ijpharm.2023.122763" @default.
- W4321438881 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36822336" @default.
- W4321438881 hasPublicationYear "2023" @default.
- W4321438881 type Work @default.
- W4321438881 citedByCount "2" @default.
- W4321438881 countsByYear W43214388812023 @default.
- W4321438881 crossrefType "journal-article" @default.
- W4321438881 hasAuthorship W4321438881A5024838157 @default.
- W4321438881 hasAuthorship W4321438881A5045709305 @default.
- W4321438881 hasAuthorship W4321438881A5045974103 @default.
- W4321438881 hasAuthorship W4321438881A5047658039 @default.
- W4321438881 hasAuthorship W4321438881A5048127513 @default.
- W4321438881 hasAuthorship W4321438881A5061230626 @default.
- W4321438881 hasAuthorship W4321438881A5080382262 @default.
- W4321438881 hasConcept C121608353 @default.
- W4321438881 hasConcept C12554922 @default.
- W4321438881 hasConcept C133936738 @default.
- W4321438881 hasConcept C178790620 @default.
- W4321438881 hasConcept C18150654 @default.
- W4321438881 hasConcept C185592680 @default.
- W4321438881 hasConcept C190283241 @default.
- W4321438881 hasConcept C200082930 @default.
- W4321438881 hasConcept C2776694085 @default.
- W4321438881 hasConcept C2778707650 @default.
- W4321438881 hasConcept C2779820397 @default.
- W4321438881 hasConcept C2781303535 @default.
- W4321438881 hasConcept C501593827 @default.
- W4321438881 hasConcept C54355233 @default.
- W4321438881 hasConcept C55493867 @default.
- W4321438881 hasConcept C86803240 @default.
- W4321438881 hasConcept C96232424 @default.
- W4321438881 hasConcept C98274493 @default.
- W4321438881 hasConceptScore W4321438881C121608353 @default.
- W4321438881 hasConceptScore W4321438881C12554922 @default.
- W4321438881 hasConceptScore W4321438881C133936738 @default.